Chemist Warehouse set for reverse listing on ASX
The deal comes after merger partner Sigma supplanted Ebos as New Zealand supplier earlier this year.
The deal would create a dominant player in pharmacy and could attract the attention of the ACCC.
Australian retail pharmacy chain Chemist Warehouse is set for a reverse listing on the ASX, with the market awaiting a deal with Sigma Healthcare.
Shares in Sigma were suspended from trading late on Wednesday, with the company informing the market of a “potential material transaction”.
Chemist
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly
credit card debit
Premium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly
credit card debit
Premium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly
credit card debit
Premium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly
credit card debit
Yearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
